Comparison of Vitamin E in Combination with Mafenamic Acid Versus Mafenamic Acid Alone for Management of Primary Dysmenorrhea

Rabia Kanwal; Mahwish Pervaiz; Qiarush Saeed; Muhammad Shahbaz Munir

doi:10.70749/ijbr.v3i6.1731

Authors

Rabia Kanwal Department of Obstetrics and Gynecology, Lahore General Hospital, Lahore, Pakistan.
Mahwish Pervaiz Department of Obstetrics and Gynecology, Allama Iqbal Memorial Teaching Hospital, Sialkot, Pakistan.
Qiarush Saeed Government Teaching Hospital, Shahdara, Lahore, Pakistan.
Muhammad Shahbaz Munir Government Hospital Samanabad, Lahore, Pakistan

DOI:

https://doi.org/10.70749/ijbr.v3i6.1731

Keywords:

Mafenamic Acid, Primary Dysmenorrhea, Pain Management, Menstrual Pain, Vitamin E

Abstract

Introduction: Painful menstrual cramps, known as primary dysmenorrhea, are a common gynecological condition that affects a great number of women across the globe. Current treatments may include use of a non steroidal anti inflammatory drugs (NSAIDS) as mafenamic acid. Recent research indicated the interaction of vitamin E with NSAIDs may intensify pain relief. Methodology: The core objective of the study was to compare the efficacy of vitamin E combined with mafenamic acid versus mafenamic acid alone for the management of primary dysmenorrhea was evaluated in randomized controlled trial. Sixty-six participants were randomly divided into two groups. Before and after treatment, pain intensity was assessed by means of the Visual Analogue Scale (VAS). Results: The reduction of pain scores in both groups was found to be significant. While combining vitamin E with mafenamic acid showed highest decrease in VAS score after tuberculosis treatment compared to mafenamic acid alone, these results were interpreted with caution. Demographic and clinical variables were similar between balanced groups. Conclusion: The addition of vitamin E to mafenamic acid may be of advantage in relieving the pain of primary dysmenorrhea rather than the use of mafenamic acid alone. These results supported previous findings, suggested that the combination of antioxidants with NSAIDs for the management of menstrual pain can be beneficial for such type of disorders.

Downloads

Download data is not yet available.

References

Itani R, Soubra L, Karout S, Rahme D, Karout L, Khojah HMJ. Primary Dysmenorrhea: Pathophysiology, Diagnosis, and Treatment Updates. Korean J Fam Med. 2022; 43(2):101-8.

https://doi.org/10.4082/kjfm.21.0103

Chen CX, Shieh C, Draucker CB, Carpenter JS. Reasons women do not seek health care for dysmenorrhea. J Clin Nurs. 2018;27(1):301–8.

https://doi.org/10.1111/jocn.13946

Sharghi M, Mansurkhani SM, Larky DA, Kooti W, Niksefat M, Firoozbakht M, et al. An update and systematic review on the treatment of primary dysmenorrhea. JBRA Assist Reprod. 2019;23(1):51–7.

https://doi.org/10.5935/1518-0557.20180083

Chen L, Tang L, Guo S, Kaminga AC, Xu H. Primary dysmenorrhea and self-care strategies among Chinese college girls: a cross-sectional study. BMJ Open. 2019;9(9):26813-9.

https://doi.org/10.1136/bmjopen-2018-026813

Rafique N, Al-Sheikh MH. Prevalence of menstrual problems and their association with psychological stress in young female students studying health sciences. Saudi Med J. 2018;39(1):67-73.

https://doi.org/10.15537/smj.2018.1.21438

Fernández-Martínez E, Onieva-Zafra MD, Parra-Fernández ML. Lifestyle and prevalence of dysmenorrhea among Spanish female university students. PLoS One. 2018;13(1):e0201894.

https://doi.org/10.1371/journal.pone.0201894

Armour M, Parry K, Al-Dabbas MA, Curry C, Holmes K, MacMillan F, et al. Self-care strategies and sources of knowledge on menstruation in 12,526 young women with dysmenorrhea: A systematic review and meta-analysis. PLoS One. 2019;14(1):103-9.

https://doi.org/10.1371/journal.pone.0220103

Nie W, Xu P, Hao C, Chen Y, Yin Y, Wang L. Efficacy and safety of over-the counter analgesics for primary dysmenorrhea A network meta-analysis. Medicine. 2020;99(19):19881-7.

https://doi.org/10.1097/md.0000000000019881

Barros GA, Calonego MA, Mendes RF, Castro RA, Faria JF, Trivellato SA, et al. The use of analgesics and risk of self-medication in an urban population sample: Cross-sectional study. Braz J Anesthesiol. 2019;69(1):529–36.

https://doi.org/10.1016/j.bjane.2019.10.006

Fernández ML, Zafra MD, Sánchez A, Pichardo JD, López MT, Martínez E. Management of Primary Dysmenorrhea among University Students in the South of Spain and Family Influence. Int J Environ Res Public Health. 2020;17(15):5570-7.

https://doi.org/10.3390/ijerph17155570

Rasheed I, Rasheed S, Mudassar AQ, Saba N, Javaid I, Saba I. Role of Vitamin E in the Treatment of Primary Dysmenorrhea. Pak J Med Health Sci. 2022;16(12) :351-3.

https://doi.org/10.53350/pjmhs20221612351

Ziaei S, Faghihzadeh S, Sohrabvand F, Lamyian M, Emamgholy T. A randomised placebo-controlled trial to determine the effect of vitamin E in treatment of primary dysmenorrhea. J Obs Gyn. 2001;108(11):1181-3.

https://doi.org/10.1016/s0306-5456(01)00279-0

Ilyas A, Iqbal S. Comparison of mean pain score with vitamin E in combination with mefenamic acid versus mefenamic acid alone for management of primary dysmenorrhea. Pak J Med Health Sci. 2019;13(1):96-98.

Sadiqa F, Fatimah M, Rehan AM, Mushtaq S, Firdous A, Jalal A. Comparative Study on Vitamin E & Mefenamic acid versus Mefenamic acid alone on mean reduction in pain in patients with Primary Dysmenorrhea. Pak J Med Health Sci. 2021;15(12):3195-7.

https://doi.org/10.53350/pjmhs2115123195

Roy S. Effects of Vitamin E and Mefenamic Acid in the Treatment of Primary Dysmenorrhoea in Tertiary Care Hospital in Bangladesh, J Med Sci Clin Res. 2021;9(12):7-10.

https://doi.org/10.18535/jmscr/v9i12.29

Yaghmaei M. Effects of Vitamin E on Ameliorating Primary Dysmenorrhea: A Systematic Review and Meta-Analysis. J Basic Clin Reprod Sci. 2020;4(1):7-11.